Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
By
Ingrid Wickelgren
13 October 2015 | 6 min read
Explore more from The Transmitter
Why emotion research is stuck—and how to move it forward
Studying how organisms infer indirect threats and understand changing contexts can establish a common framework that bridges species and levels of analysis.
Why emotion research is stuck—and how to move it forward
Studying how organisms infer indirect threats and understand changing contexts can establish a common framework that bridges species and levels of analysis.
By
Joshua P. Johansen
26 January 2026 | 0 min watch
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
By
Angie Voyles Askham
23 January 2026 | 3 min read
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
By
Claudia López Lloreda
23 January 2026 | 6 min read